Holen Sie sich die Stockscreener-App
9.38
0.11%
0.01
Handel nachbörslich:
9.50
0.12
+1.28%
Schlusskurs vom Vortag:
$9.37
Offen:
$9.21
24-Stunden-Volumen:
432.35K
Relative Volume:
0.55
Marktkapitalisierung:
$278.25M
Einnahmen:
$36.97M
Nettoeinkommen (Verlust:
$-25.54M
KGV:
-10.40
EPS:
-0.9022
Netto-Cashflow:
$-24.45M
1W Leistung:
+8.31%
1M Leistung:
-6.20%
6M Leistung:
-64.72%
1J Leistung:
-14.96%
1-Tages-Spanne:
$9.0393
$9.5299
1-Wochen-Bereich:
$8.6838
$9.5299
52-Wochen-Spanne:
$8.595
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
9.38 | 277.95M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Why The ClearPoint Neuro (CLPT) Investment Story Is Shifting On Regulatory And Partnership Risks - Yahoo Finance
Value Recap: What are the future prospects of ClearPoint Neuro IncShort Setup & AI Enhanced Trading Alerts - baoquankhu1.vn
CLPT Technical Analysis & Stock Price Forecast - Intellectia AI
ClearPoint Neuro (CLPT) price target decreased by 10.71% to 25.50 - MSN
ClearPoint Neuro (CLPT) director awarded 755 shares as stock compensation - Stock Titan
ClearPoint Neuro (CLPT) director receives 1,270-share stock grant as fees - stocktitan.net
ClearPoint Neuro (CLPT) director granted 442-share stock fee award - stocktitan.net
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - msn.com
Will ClearPoint Neuro Inc benefit from current market trends2026 Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Short Interest in ClearPoint Neuro Surges 29% in March - National Today
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March - MarketBeat
Can ClearPoint Neuro Inc be the next market leaderEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn
What are the future prospects of ClearPoint Neuro Inc2026 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vanguard amendment shows 0% stake in ClearPoint Neuro (CLPT) after realignment - Stock Titan
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Trading Systems Reacting to (CLPT) Volatility - Stock Traders Daily
ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan
Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - MarketScreener
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus
Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
CLPT Revenue Rises, Losses Widen Amid Cautious 2026 Outlook - Bitget
ClearPoint Neuro, Inc. (CLPT) reports Q4 loss, tops revenue estimates - msn.com
ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition - MSN
Clearpoint Neuro Charts Aggressive Growth Amid Rising Costs - TipRanks
ClearPoint Neuro (CLPT) Projects Strong Growth for 2026 - GuruFocus
Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up By Investing.com - Investing.com South Africa
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):